Delivery Order SPE2DB22D1017-SPE2DB25FF5WD

Award Date 2/20/25
Potential Completion Date 2/21/25
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $8,006.42 and runs through January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, Corporate Office Division. The order is for the supply of 4,566,077,663 units of Velphoro 500 mg chewable tablets in 90-count packages, at a firm fixed price of $2,267.76. The order does not have a set-aside designation. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Velphoro 500 mg chewable tablets, a medication used in the treatment of hyperphosphatemia in chronic kidney disease patients. The contract has a ceiling value of $1,888.29 and a performance period ending on July 24, 2024. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,835.75 firm fixed-price delivery order is for the supply of Velphoro 500 mg chewable tablets, a medication used in the treatment of hyperphosphatemia. The contract has an ultimate completion date of November 10, 2022 and was awarded on November 9, 2022. This delivery order is part of a larger $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,446.71, is for the delivery of Velphoro 500 mg chewable tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of August 30, 2024. The contract is not set aside for any specific business type. Amerisourcebergen has significant Indefinite Delivery Contracts (IDCs) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,981.91, is for the delivery of Velphoro 500 mg chewable tablets. The contract type is Firm Fixed Price, and the ultimate completion date is January 18, 2024. This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Velphoro 500 mg chewable tablets. The contract is a firm fixed-price delivery order with a ceiling value of $9,402.10 and a period of performance through November 4, 2024. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $22,931.11 and a period of performance through November 22, 2022. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,347.98 Firm Fixed Price Delivery Order is for the supply of Velphoro 500 mg chewable tablets, a medication used in the treatment of hyperphosphatemia. The contract has a ceiling value of $16,347.98 and an ultimate completion date of February 6, 2025. This award is not designated as a set-aside contract. The...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Velphoro 500 mg chewable tablets. The award, with a ceiling value of $4,944.98 and a completion date of April 12, 2024, is not associated with any set-aside designations. Amerisourcebergen Drug Corp serves as a prime contractor for DLA to provide a range of pharmaceutical and medical supplies...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF5WD
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,004.74, is for the provision of Velphoro 500 mg chewable tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The contract will be performed in Conshohocken, Pennsylvania, and has a completion date of February 21, 2025.

Generated 5/22/25, 8:33 PM